Bionl.ai
Basel A. is a seasoned expert in bioinformatics and computational biology, currently serving as a Consultant for Kingdom Health and as Director of Computational Biology at Nucleome Therapeutics. With experience in leading teams to explore innovative disease treatments, Basel has held significant roles at Bionl.ai, Phi Science Institute, Genetics and Bioinformatics Association, and Sensyne Health. Previous academic positions include postdoctoral research at the University of Oxford and a research assistant role at Brunel University London. Basel holds multiple degrees, including PhDs from the University of Liverpool in Computational Biology and Bioinformatics, and a BSc in Computer Engineering from the University of Jordan.
This person is not in any teams
This person is not in any offices
Bionl.ai
1 followers
Bionl.ai is an NLP-enabled biomedical and bioinformatics research platform. Bionl aims to enable healthcare scientists and professionals to conduct bioinformatics research without the need to acquire programming expertise or hire bioinformaticians. Our solution, which leverages state-of-the-art large language models such as GPT-3, empowersscientists to do basic and advanced bioinformatics exploration through natural language prompts.